Fortress Biotech (FBIO) Misses Q3 EPS by 33c

Fortress Biotech (NASDAQ: FBIO) reported Q3 EPS of ($0.46), $0.33 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Fortress Biotech (FBIO) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Copart (CPRT) Misses Q4 EPS by 4c
• Adobe beats Q3 targets, but soft Q4 sales guidance triggers dip